(*contributed equally to this work) 发布: 2020年03月20日第10卷第6期 DOI: 10.21769/BioProtoc.3559 浏览次数: 8699
评审: Oneil G. BhalalaXiaoyu LiuAnonymous reviewer(s)
Abstract
In diseases such as glaucoma, the failure of retinal ganglion cell (RGC) neurons to survive or regenerate their optic nerve axons underlies partial and, in some cases, complete vision loss. Optic nerve crush (ONC) serves as a useful model not only of traumatic optic neuropathy but also of glaucomatous injury, as it similarly induces RGC cell death and degeneration. Intravitreal injection of adeno-associated virus serotype 2 (AAV2) has been shown to specifically and efficiently transduce RGCs in vivo and has thus been proposed as an effective means of gene delivery for the treatment of glaucoma. Indeed, we and others routinely use AAV2 to study the mechanisms that promote neuroprotection and axon regeneration in RGCs following ONC. Herein, we describe a step-by-step protocol to assay RGC survival and regeneration in mice following AAV2-mediated transduction and ONC injury including 1) intravitreal injection of AAV2 viral vectors, 2) optic nerve crush, 3) cholera-toxin B (CTB) labeling of regenerating axons, 4) optic nerve clearing, 5) flat mount retina immunostaining, and 6) quantification of RGC survival and regeneration. In addition to providing all the materials and procedural details necessary to execute this protocol, we highlight its advantages over other similar published approaches and include useful tips to ensure its faithful reproduction in any modern laboratory.
Keywords: Glaucoma (青光眼)Background
Glaucoma is the leading cause of irreversible blindness worldwide characterized by the progressive degeneration and loss of retinal ganglion cells (RGCs), the central projecting neurons that form the optic nerve connecting the retina to the brain (Quigley, 2011; Tham et al., 2014). Glaucomatous RGC cell death is thought to be induced, in part, by an increase in intraocular pressure (IOP) and concomitant compression of RGC axons as they exit the retina through the optic nerve head (Quigley, 2011; Chang and Goldberg, 2012). Several models of glaucoma in rodents have been developed to study the cellular and molecular mechanisms that underlie RGC degeneration including optic nerve crush (ONC), intracameral injection of microbeads, and intravitreal injection of silicon oil (Sappington et al., 2010; Tang et al., 2011; Templeton and Geisert, 2012; Ito et al., 2016; Zhang et al., 2019). While both the microbead and silicon injection models recapitulate the increase in IOP and induce progressive RGC cell death associated with glaucoma, they are not conducive to study axon regeneration due to variability of the insult and incomplete degeneration of RGC axons. Alternatively, ONC has served as a useful preclinical model to study both neuronal survival and regeneration as it induces significant RGC death with little variability and severs all axons allowing confidence that any fibers found past the site of injury are regenerating, rather than spared. Adeno-associated virus serotype 2 (AAV2) specifically and efficiently transduces RGCs following intravitreal injection, making it the principal means to deliver genes (recombinant DNA, shRNA, etc.) into RGCs (Martin et al., 2002; Nickells et al., 2017). Indeed, we’ve reported the use of AAV2 to deliver therapeutic peptides and shRNA to promote RGC survival and axon regeneration following ONC injury (Moore et al., 2009; Apara et al., 2017; Galvao et al., 2018; Boczek et al., 2019). Here, we describe a comprehensive protocol detailing the use of AAV2 in combination with ONC as a means to study the mechanisms that promote neuroprotection and regeneration, and to identify and characterize candidate molecules with therapeutic potential for the treatment of glaucoma and other optic neuropathies.
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2020 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
分类
神经科学 > 神经系统疾病 > 动物模型
神经科学 > 基础技术
细胞生物学 > 基于细胞的分析方法 > 创伤修复
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link